Vivace Therapeutics, Inc.

General Information
Company Name
Vivace Therapeutics, Inc.
Founded Year
2014
Location (Offices)
San Mateo, United States +1
Founders / Decision Makers
Sofie Qiao - President and Chief Executive Officer Amy Pfeiffer - Director Of Operations Leonard Post - Chief Scientific Officer Tuomas Holmberg - Vice President of Corporate Development Tracy Tang - Vice President of Biology Andrei Konradi - Vice President of Chemistry
Number of Employees
9
Industries
Biotechnology, Health Care, Health and Wellness
Funding Stage
Series C
Social Media

Vivace Therapeutics, Inc. - Company Profile

Vivace Therapeutics, Inc. is a venture-backed, San Mateo-based biotechnology company founded in 2014. Specializing in oncology-focused drug discovery and development, the company's portfolio includes small molecule programs targeting the YAP pathway and bi-specific programs. The scientific founders, Dr. Kun-liang Guan of UCSD, Dr. Bin Liu, and Dr. Sheng Ding of UCSF, bring a wealth of expertise to the company. In December 2020, Vivace Therapeutics successfully secured a $30.00M Series C investment from major players in the investment world, including Canaan Partners, RA Capital Management, and Boxer Capital. With a focus on revolutionizing cancer treatment, Vivace Therapeutics has positioned itself as an innovative player in the health care industry. For further details on the company and its cutting-edge programs, visit www.vivacetherapeutics.com.

Taxonomy: Vivace Therapeutics, oncology, drug discovery, bi-specific programs, small molecule programs, YAP pathway, San Mateo, California, venture-backed, UCSD, UCSF, clinical trials, pharmaceuticals

Funding Rounds & Investors of Vivace Therapeutics, Inc. (3)

View All
Funding Stage Amount No. Investors Investors Date
Series C $30.00M 3
Canaan Partners, investor in Vivace Therapeutics, Inc.'s Series C round RA Capital Management, investor in Vivace Therapeutics, Inc.'s Series C round Boxer Capital, investor in Vivace Therapeutics, Inc.'s Series C round
16 Dec 2020
Series B $25.00M 6
Canaan Partners, investor in Vivace Therapeutics, Inc.'s Series B round Cenova, investor in Vivace Therapeutics, Inc.'s Series B round Mission Bay Capital, investor in Vivace Therapeutics, Inc.'s Series B round WuXi Healthcare Ventures, investor in Vivace Therapeutics, Inc.'s Series B round Mission BioCapital, investor in Vivace Therapeutics, Inc.'s Series B round
Sequoia Capital 		28 Jun 2017
Series A $15.00M 1
Canaan Partners, investor in Vivace Therapeutics, Inc.'s Series A round
01 Jan 2015

Latest News of Vivace Therapeutics, Inc.

View All

No recent news or press coverage available for Vivace Therapeutics, Inc..

Similar Companies to Vivace Therapeutics, Inc.

View All
Together Senior Health - Similar company to Vivace Therapeutics, Inc.
Together Senior Health Helping people with memory loss to maintain independence
Nine Square Therapeutics - Similar company to Vivace Therapeutics, Inc.
Nine Square Therapeutics A quest to alter the trajectory of neurodegenerative disease
Warmilu - Similar company to Vivace Therapeutics, Inc.
Warmilu Spread the warmth, save lives.
Onward - Similar company to Vivace Therapeutics, Inc.
Onward The Total Transportation Solution for Hospitals, PACE, & Transit Agencies. Featuring Door-Through-Door #CompanionRides
SB Wellness Group - Similar company to Vivace Therapeutics, Inc.
SB Wellness Group Your employee's health is our priority
Circle Decoration Circle Decoration

Want to dive deeper into Vivace Therapeutics, Inc.? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now